Riskpilot← Back to searchSign inGet full accessTemax AB
ABActiveOrg 5566271234Hornsgatan 11Manufacture of pharmaceutical preparations · NACE 2120Est. 20025-9 employees
Revenue 2024
SEK 11M
+13% vs 2023
EBITDA margin
9.1%
+6% vs 2023
Equity ratio
60.3%
Financial strength
Net profit 2024
SEK 547K
-38% vs 2023
| Revenue | SEK 11M | +13% |
| EBITDA | SEK 1M | +6% |
| Net profit | SEK 547K | -38% |
| Total assets | SEK 4,1M | +16% |
| Equity | SEK 2,4M | -2% |
| Employees | — | — |
Legal name
Temax AB
Org number
5566271234
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
5 juni 2002
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet skall vara att utveckla och marknadsföra linement, massageoljor samt hygienprodukter för utvärtes bruk.
Address
Hornsgatan 11
Phone
+4624382669
Email
temax.hakan@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 10 172 | 9 619 | 9 248 | 9 755 | 10 998 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 320 | 1 069 | 813 | 949 | 1 003 |
| Depreciation & amort. | −23 | −28 | −47 | −52 | −56 |
| EBIT | 1 297 | 1 041 | 766 | 897 | 947 |
| Net financials | — | −8 | −4 | 6 | 8 |
| Profit before tax | 1 452 | 1 153 | 983 | 1 128 | 706 |
| Tax | −320 | −249 | −218 | −242 | −159 |
| Net profit | 1 132 | 904 | 765 | 886 | 547 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 642 | 3 687 | 3 617 | 3 484 | 4 058 |
| Equity | 1 748 | 2 051 | 2 216 | 2 502 | 2 449 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 330 | 1 191 | 1 176 | 982 | 1 359 |
| Total debt | 1 330 | 1 191 | 1 176 | 982 | 1 359 |
EBITDA margin
9.1%
This company
15.8%
Market median
-42% vs market
20202024
Equity ratio
60.3%
This company
38.2%
Market median
+58% vs market
20202024
Return on equity
22.3%
This company
18.4%
Market median
+21% vs market
20202024
Net profit margin
5.0%
This company
8.1%
Market median
-38% vs market
20202024
Asset turnover
2.71×
This company
1.12×
Market median
+142% vs market
20202024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TH Chief Executive Officer | Chief Executive Officer | 2022 |
PK Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Temax AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tord Håkan Olsson | Chief Executive Officer | 0 companies |
| Pär Karl Erik Hagman | Audit | 0 companies |
| Per Johan Malmborg | Deputy Board Member | 0 companies |